High-flow nasal cannulae for respiratory support in adult intensive care patients

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 5, 2017, Pages

  Corley, Amanda ^a,b   Rickard, Claire M ^b   Aitken, Leanne M ^b,c,d   Johnston, Amy ^e   Barnett, Adrian ^f   Fraser, John F ^a   Lewis, Sharon R ^g   Smith, Andrew F ^g  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d CITY UNIVERSITY   (United Kingdom)

^e GOLD COAST HOSPITAL AND HEALTH SERVICE   (Australia)

^f QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^g ROYAL LANCASTER INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE RESPIRATORY FAILURE; ADULT; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BILEVEL POSITIVE AIRWAY PRESSURE; BLOOD OXYGEN TENSION; BREATHING RATE; CARBON DIOXIDE CLEARANCE; CARDIOPULMONARY INSUFFICIENCY; CLINICAL EFFECTIVENESS; DATA EXTRACTION; EVIDENCE BASED MEDICINE; FRACTION OF INSPIRED OXYGEN; HEALTH CARE COST; HEART ARRHYTHMIA; HIGH FLOW NASAL CANNULA; HUMAN; INTENSIVE CARE PATIENT; INTENSIVE CARE UNIT; LENGTH OF STAY; LOW FLOW OXYGEN; MORTALITY; NASAL CANNULA; NOSOCOMIAL PNEUMONIA; OUTCOME ASSESSMENT; OXYGEN DESATURATION; OXYGEN SATURATION; OXYGEN THERAPY; PATIENT; PATIENT REPORTED OUTCOME; PATIENT SAFETY; PNEUMONIA; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PSEUDOOBSTRUCTION; QUALITY CONTROL; RESPIRATORY TRACT PARAMETERS; REVIEW; RISK BENEFIT ANALYSIS; SELECTION BIAS; SENSITIVITY ANALYSIS; SEPTIC SHOCK; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; ADVERSE EFFECTS; HOSPITAL MORTALITY; INTENSIVE CARE; INTUBATION; META ANALYSIS; PATIENT-REPORTED OUTCOME; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS SYNDROME, ADULT;

ADULT; CRITICAL CARE; HOSPITAL MORTALITY; HUMANS; INTUBATION; LENGTH OF STAY; OXYGEN INHALATION THERAPY; PATIENT REPORTED OUTCOME MEASURES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT FAILURE;

EID: 85020037250     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010172.pub2     Document Type: Review

References (81)

1. Chanques G, Riboulet F, Molinari N, Carr J, Jung B, Prades A, et al. Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study. Minerva Anestesiologica 2013;79(12):1344-55. [PUBMED: 23857440]5668726
2. Corley A, Bull T, Spooner AJ, Barnett AG, Fraser JF. Direct extubation onto high-flow nasal cannulae post-cardiac surgery versus standard treatment in patients with a BMI ≥ 30: a randomised controlled trial. Intensive Care Medicine 2015;41(5):887-94. [PUBMED: 25851385]5668728
3. Cuquemelle E, Pham T, Papon J-F, Louis B, Danin P-E, Brochard L. Heated and humidified high-flow oxygen therapy reduces discomfort during hypoxaemic respiratory failure. Respiratory Care 2012;57(10):1571-7. [PUBMED: 22417569]5668730
4. Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. New England Journal of Medicine 2015;372(23):2185-96. [PUBMED: 25981908]5668732
5. Lemiale V, Mokart D, Mayaux J, Lambert J, Rabbat A, Demoule A, et al. The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial. Critical Care (London, England) 2015;19:380. [PUBMED: 26521922]5668734
6. Antonicelli F, Cataldo A, Festa F, Idone R, Moccaldo A, Antonelli M, et al. High-flow oxygen therapy through nasal cannulae versus low-flow oxygen therapy via Venturi mask after extubation in adult, critically ill patients (Abstract). 31st International Symposium on Intensive Care and Emergency Medicine. Brussels, Belgium, March 2011. 5668736
7. Idone FA, Festa R, Antonicelli F, Di Muzio F, Maniglia D, Cataldo A, et al. Nasal high-flow oxygen therapy vs. standard oxygen therapy via venturi mask after extubation: preliminary results of a randomized, controlled trial (Abstract). 23rd Annual Congress of the European Society of Intensive Care Medicine, ESICM Barcelona Spain. October 2010. 5668737
8. Maggiore SM, Idone FA, Vaschetto R, Festa R, Cataldo A, Antonicelli F, et al. Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. American Journal of Respiratory and Critical Care Medicine 2014;190(3):282-8. [PUBMED: 25003980]5668738
9. Moccaldo A, Vaschetto R, Bernini V, Antonicelli F, Festa R, Idone F, et al. Oxygen after extubation: comparison between high flow system (Optiflow) and Venturi mask. [Ossigenoterapia dopo estubazione: confronto tra sistema ad alti flussi (Optiflow) e maschera venturi]. Minerva Anestesiology 2011;77(10 Suppl 2):169. 5668739
10. Parke RL, McGuinness SP, Eccleston ML. A preliminary randomised controlled trial to assess effectiveness of nasal high-flow oxygen in intensive care patients. Respiratory Care 2011;56(3):265-70. [PUBMED: 21255498]5668741
11. Parke R, McGuinness S, Dixon R, Jull A. Open-label, phase II study of routine high-flow nasal oxygen therapy in cardiac surgical patients. British Journal of Anaesthesia 2013;111(6):925-31. [PUBMED: 23921199 ]5668743
12. Rittayamai N, Tscheikuna J, Rujiwit P. High-flow nasal cannula versus conventional oxygen therapy after endotracheal extubation: a randomized crossover physiologic study. Respiratory Care 2014;59(4):485-90. [PUBMED: 24046462]5668745
13. Riessen R, Schwabbauer N, Berg B, Blumenstock G, Haap M, Hetzel J. Nasal high-flow oxygen in patients with hypoxic respiratory failure: effect of functional and subjective respiratory parameters compared to conventional oxygen therapy and noninvasive ventilation (Abstract). 32nd International Symposium on Intensive Care and Emergency Medicine. Brussels, Belgium. March 2012. 5668747
14. Schwabbauer N, Berg B, Blumenstock G, Haap M, Hetzel J, Riessen R. Nasal high-flow oxygen therapy in patients with hypoxic respiratory failure: effect on functional and subjective respiratory parameters compared to conventional oxygen therapy and non-invasive ventilation (NIV). BMC Anesthesiology 2014;14(66):1-7. [PUBMED: 25110463]5668748
15. Stephan F, Barrucand B, Petit P, Rezaiguia-Delclaux S, Medard A, Delannoy B. Bilevel positive airway pressure versus OPTIFLOW in hypoxemic patients after cardiothoracic surgery (the BiPOP study): a multicenter, randomized, noninferiority, open trial (Abstract). American Journal of Respiratory and Critical Care Medicine. 2014; Vol. 189:A6572. 5668752
16. Stephan F, Barrucand B, Petit P, Rezaiguia-Delclaux S, Medard A, Delannoy B, et al. Bipap non invasive ventilation compared to Optiflow (R) System in patients with hypoxemia after cardiothoracic surgery: multicenter, randomized, non-inferiority and open (Abstract). Annales Francaises D Anesthesie Et De Reanimation. 2014; Vol. 33:A72. 5668750
17. Stephan F, Barrucand B, Petit P, Rezaiguia-Delclaux S, Medard A, Delannoy B, et al. High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA 2015;313(23):2331-9. [PUBMED: 25980660]5668751
18. Baneton S, Cabillic M, Nicolet J, Rigal J-C, Rozec B. Hypoxémie grave après chirurgie cardiaque: évaluation d'un système d'oxygénothérapie nasale à haut débit. Kinésithérapie, la Revue 2014; Vol. 14, issue 154:43-7. 5668754
19. Besch G, Barrande Y, Barrucand B, Ferreira D, Samain E, Stephan F, et al. Comparison of the alveolar recruiting effect between non-invasive mechanical ventilation and Optiflow. Intensive Care Medicine, 27th Annual Congress, Barcelona, Spain, 27th September - 1st October. 2014; Vol. 40 (Suppl 1):A0241. 5668756
20. Braunlich J, Beyer D, Mai D, Hammerschmidt S, Seyfarth H-J, Wirtz H. Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration 2013;85:319-25. [PUBMED: 23128844]5668758
21. Curley GF, Laffy JG, Zhang H, Slutsky AS. Noninvasive respiratory support for acute respiratory failure-high flow nasal cannula oxygen or non-invasive ventilation?. Journal of Thoracic Disease 2015; Vol. 7, issue 7:1092-7. [2015317531]5668760
22. Parke RL, McGuinness SP. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respiratory Care 2013;58(10):1621-4. [PUBMED: 23513246]5668762
23. Pinto T, Vaz M, Goncalves MR, Magalhães A, Winck JC. Prospective randomized trial comparing oxygen administration during FOB: conventional nasal cannula versus HFNC (Optiflow). Revista Portuguesa de Pneumologia. 2012; Vol. 18 (Esp Cong 1):16. 5668764
24. Simon M, Braune S, Frings D, Wiontzek A.-K, Klose H, Kluge S. High-flow nasal cannula oxygen versus non-invasive ventilation in patients with acute hypoxaemic respiratory failure undergoing flexible bronchoscopy - a prospective randomised trial. Critical Care 2014;18(6):712. [PUBMED: 25529351]5668766
25. Tiruvoipati R, Lewis D, Haji K, Botha J. High-flow nasal oxygen vs high-flow face mask: a randomized crossover trial in extubated patients. Journal of Critical Care 2010;25(3):463-8. [PUBMED: 19781896]5668768
26. Vourc'h M, Asfar P, Volteau C, Bachoumas K, Clavieras N, Egreteau PY, et al. High-flow nasal cannula oxygen during endotracheal intubation in hypoxemic patients: a randomized controlled clinical trial. Intensive Care Medicine 2015;41(9):1538-48. [PUBMED: 25869405]5668770
27. Futier E, Paugam-Burtz C, Godet T, Khoy-Ear L, Rozencwajg S, Delay JM, et al. Effect of early postextubation high-flow nasal cannula vs conventional oxygen therapy on hypoxaemia in patients after major abdominal surgery: a French multicentre randomised controlled trial (OPERA). Intensive Care Medicine 2016;42(12):1888-98. [PUBMED: 27771739]5668772
28. Hernandez G, Vaquero C, Colinas L, Cuena R, Gonzalez P, Canabal A, et al. Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients:a randomized clinical trial. JAMA 2016;316(15):1565-74. [PUBMED: 27706464]5668774
29. Hernandez G, Vaquero C, Gonzalez P, Subira C, Frutos-Vivar F, Rialp G, et al. Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial. JAMA 2016;315(13):1354-61. [PUBMED: 26975498]5668776
30. Lemiale V, Resche-Rigon M, Mokart D, Pene F, Argaud L, Mayaux J, et al. High-flow nasal cannula oxygenation in immunocompromised patients with acute hypoxemic respiratory failure: a Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique study. Critical Care Medicine. 2016; Vol. 20:20. [PUBMED: 27655324]5668778
31. Lemiale V, Resche-Rigon M, Mokart D, Pene F, Faucher E, Guitton C, et al. High-flow nasal cannula for acute respiratory failure in immunocompromised patients. Annals of Intensive Care. Conference: French Intensive Care Society, International Congress Reanimation. 2016; Vol. 6:no pagination. 5668779
32. Perbet S, Gerst A, Chabanne R, Soummer A, Faure JS, Pascal J, et al. High-flow nasal oxygen cannula versus conventional oxygen therapy to prevent postextubation lung aeration loss: a multicentric randomized control lung ultrasound study. 27th Annual Congress of the European Society of Intensive Care Medicine. Barcelona, Spain. September 2014. 5668781
33. Saeed A, Wagih K, Huusein N. Evaluation of nasal Optiflow device in management of COPD patients in acute exacerbations. European Respiratory Journal. Conference: European Respiratory Society Annual Congress 2015; Vol. 46, issue no pagination. [72105945]5668783
34. NCT01166256 . Comparison between high-flow nasal cannula system and non-invasive ventilation in acute hypoxemic respiratory failure [Prospective, open-labeled, randomized controlled trial of comparison between high-flow nasal cannula system and non-invasive ventilation in acute hypoxemic respiratory failure]. https://clinicaltrials.gov/ct2/show/NCT01166256?term=NCT01166256&rank=1 (first received 19 July 2010). 5668785
35. NCT01617252 . High flow nasal oxygen therapy for hypoxemy after cardiac surgery. https://clinicaltrials.gov/ct2/show/NCT01617252?term=NCT01617252&rank=1 (first received 8 June 2012). 5668787
36. NCT01702779 . Nasal humidified high flow oxygen during weaning from mechanical ventilation: ultrasonography study. https://clinicaltrials.gov/ct2/show/NCT01702779?term=NCT01702779&rank=1 (first received 24 April 2012). 5668789
37. NCT01782430 . PREoxygenation for the intubation of hypoxemic patients: comparison of standard oxygenation, high flow nasal oxygen therapy, and noninvasive ventilation. https://clinicaltrials.gov/ct2/show/NCT01782430?term=NCT01782430&rank=1 (first received 31 January 2013). 5668791
38. NCT01820507 . Extubation failure prevention in high risk patients by high-flow conditioned oxygen therapy vs. standard oxygen therapy [Prevention of post-extubation respiratory failure in high risk patients by high-flow conditioned oxygen therapy versus standard oxygen therapy]. https://clinicaltrials.gov/ct2/show/NCT01820507?term=NCT01820507&rank=1 (first received 26 March 2013). 5668793
39. NCT01994928 . Preoxygenation in the intensive care unit using a nose-mouth mask versus high-flow nasal cannula oxygen [Prospective randomised study on preoxygenation in the intensive care unit using a nose-mouth mask versus high flow nasal cannula oxygen]. https://clinicaltrials.gov/ct2/show/study/NCT01994928?term=NCT01994928&rank=1 (first received 20 November 2013). 5668795
40. NCT02107183 . Impact of nasal high-flow vs Venturi mask oxygen therapy on weaning outcome: a multicenter, randomized, controlled trial. https://clinicaltrials.gov/ct2/show/NCT02107183?term=NCT02107183&rank=1 (first received 4 April 2014). 5668797
41. NCT02123940 . Treatment strategy in patients with high-risk of postextubation distress in ICU based on a lung ultrasound score versus standard strategy. https://clinicaltrials.gov/ct2/show/NCT02123940?term=NCT02123940&rank=1 (first received 11 April 2014). 5668799
42. UMIN000008778 . Evaluation of nasal high flow oxygen therapy [Evaluation of nasal high flow oxygen therapy for severe acute hypoxemic respiratory failure]. https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010317 (first received 27 August 2012). 5668801
43. Behrendt CE. Acute respiratory failure in the United States: incidence and 31-day survival. Chest 2000;118(4):1100-5. [PUBMED: 11035684]
44. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995;310:170. [PUBMED: 7833759]
45. Chanques G, Constantin JM, Sauter M, Jung B, Sebbane M, Verzilli D, et al. Discomfort associated with under humidified high-flow oxygen therapy in critically ill patients. Intensive Care Medicine 2009;35(6):996-1003. [PUBMED: 19294365]
46. Corley A, Caruana LR, Barnett AG, Tronstad O, Fraser JF. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. British Journal of Anaesthesia 2011;107(6):998-1004. [DOI: 10.1093/bja/aer265]
47. Dysart K, Miller TL, Wolfson MR, Shaffer TH. Research in high flow therapy: mechanisms of action. Respiratory Medicine 2009;103(10):1400-5. [PUBMED: 19467849]
48. El-Khatib MF. High-flow nasal cannula oxygen therapy during hypoxemic respiratory failure. Journal of Critical Care 2012;57(10):1696-8. [PUBMED: 23013907]
49. Fisher & Paykel Healthcare. Auckland, New Zealand. www.fphcare.co.nz (accessed 16 June 2015).
50. Gattinoni L, Carlesso E, Langer T. Towards ultraprotective mechanical ventilation. Current Opinion in Anaesthesiology 2012;25(2):141-7. [PUBMED: 22246461]
51. Gotera C, Lobato SD, Pinto T, Winck JC. Clinical evidence on high flow oxygen therapy and active humidification in adults. Revista Portuguesa De Pneumologia 2013;19(5):217-27.
52. Gregoretti C, Confalonieri M, Navalesi P, Squadrone V, Frigerio P, Beltrame F, et al. Evaluation of patient skin breakdown and comfort with a new face mask for non-invasive ventilation: a multi-center study. Intensive Care Medicine 2002;28(3):278-84. [PUBMED: 11904656]
53. Groves N, Tobin A. High flow nasal oxygen generates positive airway pressure in adult volunteers. Australian Critical Care 2007;20(4):126-31. [PUBMED: 17931878]
54. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336(7651):995-8. [PUBMED: 18456631]
55. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
56. Kernick, J, Magarey, J . What is the evidence for the use of high flow nasal cannula oxygen in adult patients admitted to critical care units? A systematic review. Australian Critical Care 2010;23:53-70. [PUBMED: 20206546]
57. Lee JH, Rehder KJ, Williford L, Cheifetz IM, Turner DA. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Medicine 2013;392:247-57. [DOI: 10.1007/s00134-012-2743-5.]
58. Lellouche F, Maggiore SM, Deye N, Taille S, Pigeot J, Harf A, et al. Effect of the humidification device on the work of breathing during noninvasive ventilation. Intensive Care Medicine 2002;28(11):1582-9. [PUBMED: 12415444]
59. Mayfield S, Jauncey-Cooke J, Hough JL, Schibler A, Gibbons K, Bogossian F. High-flow nasal cannula therapy for respiratory support in children. Cochrane Database of Systematic Reviews 2014, Issue 3. [DOI: 10.1002/14651858.CD009850.pub2]
60. Mehta S, Hill NS. Noninvasive ventilation. American Journal of Respiratory and Critical Care Medicine 2001;163(2):540-77. [PUBMED: 11179136]
61. Morandi A, Brummel NE, Ely EW. Sedation, delirium and mechanical ventilation: the 'ABCDE' approach. Current Opinion in Critical Care 2011;17(1):43-9. [PUBMED: 21169829]
62. Muscedere J, Dodek P, Keenan S, Fowler R, Cook D, Heyland D. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: diagnosis and treatment. Journal of Critical Care 2008;23:138-47. [PUBMED: 18359431]
63. Nava S, Hill N. Non-invasive ventilation in acute respiratory failure. Lancet 2009;374(9685):250-9. [PUBMED: 19616722]
64. Nelson BJ, Weinert CR, Bury CL, Marinelli WA, Gross CR. Intensive care unit drug use and subsequent quality of life in acute lung injury patients. Critical Care Medicine 2000;28(11):3626-30. [PUBMED: 11098964]
65. O'Driscoll BR, Howard LS, Davison AG. British Thoracic Society Guideline for emergency oxygen use in adult patients. Thorax 2008;63 Suppl 6:vi1-68. [PUBMED: 18838559]
66. Parke R, McGuinness S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. British Journal of Anaesthesia 2009;103(6):886-90. [PUBMED: 19846404]
67. Price AM, Plowright C, Makowski A, Misztal B. Using a high-flow respiratory system (Vapotherm) within a high dependency setting. Nursing and Critical Care 2008;13(6):298-304. [PUBMED: 19128313]
68. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
69. Ricard, J-D . High flow nasal oxygen in acute respiratory failure. Minerva Anestesiologica 2012;78(7):836-41. [PUBMED: 22531566]
70. Roca O, Riera J, Torres F, Masclans JR. High-flow oxygen therapy in acute respiratory failure. Respiratory Care 2010;55(4):408-13. [PUBMED: 20406507]
71. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Critical Care Medicine 2005;33(10):2184-93. [PUBMED: 16215368]
72. Salah B, Dinh Xuan AT, Fouilladieu JL, Lockhart A, Regnard J. Nasal mucociliary transport in healthy subjects is slower when breathing dry air. European Respiratory Journal 1988;1(9):852-5. [PUBMED: 3229484]
73. Sasaki H, Yamakage M, Iwasaki S, Mizuuchi M, Namiki A. Design of oxygen delivery systems influences both effectiveness and comfort in adult volunteers. Canadian Journal of Anaesthesia 2003;50(10):1052-5. [PUBMED: 14656787]
74. Scala R. High-flow nasal oxygen therapy: one more chance for extubation?. Respiratory Care 2014;59(4):609-12. [DOI: 10.4187/respcare.03157]
75. Shelly MP, Nightingale P. ABC of intensive care: respiratory support. BMJ 1999;318(7199):1674-7. [PUBMED: 10373174]
76. Sztrymf B, Messika J, Bertrand F, Hurel D, Leon R, Dreyfuss D, et al. Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Medicine 2011;37(11):1780-6. [PUBMED: 21946925]
77. Sztrymf B, Messika J, Mayot T, Lenglet H, Dreyfuss D, Ricard JD. Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study. Journal of Critical Care 2012;27(3):e9-13. [PUBMED: 21958974]
78. Ward JJ. High-flow oxygen administration by nasal cannula for adult and perinatal patients. Respiratory Care 2013;58(1):98-122. [DOI: 10.4187/respcare.01941]
79. Wilkinson D, Andersen C, O'Donnell CPF, De Paoli AG. High flow nasal cannula for respiratory support in preterm infants. Cochrane Database of Systematic Reviews 2011, Issue 5. [DOI: 10.1002/14651858.CD006405.pub2]
80. Zevola DR, Maier CB. Use of nasal cannula versus face mask after extubation in patients after cardiothoracic surgery. Critical Care Nurse 2001;21(3):47-53. [PUBMED: 11858676]
81. Corley A, Rickard CM, Aitken LM, Johnston A, Barnett A, Fraser JF. High flow nasal cannulae for respiratory support in adult intensive care patients. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD010172]